Table 2. Risk of Bias in Studies.
Source | Intention-to-treat analysis | Allocation concealment | Blinding | Lost to follow up |
Katafuchi R 2008 [28] | No | Unclear | Unclear | No lost to follow-up |
Koike M 2008[29] | Yes | Unsealed envelops | Yes: patients and caregivers | No lost to follow-up |
Pozzi C 2004[30] | Yes | Yes | Unclear | No lost to follow-up |
Moriyama T 2004[31] | Yes | Unclear | No | No lost to follow-up |
Katafuchi R 2003[32] | No | Yes | No | Lost to follow-up: 13 patients |
Shoji T 2000[33] | No | Yes | No | Lost to follow-up:2 patients |
K.N.Lai 1986[34] | No | Unclear | No | No lost to follow-up |
Kobayashi Y 1996[35] | No | Inadequate | No | Lost to follow-up:44 patients |
Welch TR 1992[36] | Unclear | Yes | Yes: patients and investigators | Lost to follow-up:3 patients |
Kobayashi Y 1988[37] | No | Unclear | Unclear | No lost to follow-up |
Julian BA 1993[38] | No | Yes | Unclear | Lost to follow-up:2 patients |
Uzu T 2003[39] | No | No | Unclear | No lost to follow-up |
Manno C[21] | Yes | Yes | No | Lost to follow-up: 6 patients |
Lv J[22] | Yes | Yes | No | Lost to follow-up: 3 patients |
Locatelli F 2001[40] | Yes | Unclear | Unclear | Lost to follow-up: 12 patients |